Pharmafile Logo

payer survey

- PMLiVE

Hancock says UK genome service is now ‘rolling out’

Health secretary also announces a £240m social care boost

- PMLiVE

GSK to reverse ‘no KOLs’ policy, admitting it has hit marketing

Company seeking to revive lacklustre marketing performance

- PMLiVE

Janssen’s single tablet Symtuza gains NHS England funding 

Janssen and Gilead combination first to reach patients

- PMLiVE

Checkpoint inhibitor scientists win Nobel Prize

Winners Allison and Honjo inspired efforts to eliminate tumour cells efficiently

Hannah – Celebrating Ten Magical Years at Lucid Group

Given that Lucid Group is only 11 years old itself, it’s a special occasion for the company to recognise significant Lucid anniversaries, especially for those with a decade of service...

Lucid Group Communications Limited

The dark side of direct-to-consumer genetic tests

Direct-to-consumer testing is an affordable way to better understand your DNA, but is this a leap forward in innovation or another layer clouding an already complex market? From anxious patients...

Blue Latitude Health

- PMLiVE

Pfizer names next CEO as Read retires

Company's board elects current chief operating officer Dr Albert Bourla

- PMLiVE

Novo Nordisk to launch connected insulin pens

Also partners with Dexcom, Glooko and Roche on digital platforms

- PMLiVE

China’s Innovent to start US trials of anti-CD47 cancer drug

Sintilimab will be initially positioned for the Chinese market

- PMLiVE

Insmed claims first FDA okay for limited population antibiotic

Arikayce is cleared to treat lung disease caused by MAC

Porterhouse BPS logo

Behaviour change: Five things you probably suspected, but weren’t sure about…

Fabrice Allum, managing director of Porterhouse Insights, looks at behaviour change and introduces the Porterhouse BPS.

Porterhouse Medical Group

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links